Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001789769-22-000079
Filing Date
2022-09-06
Accepted
2022-09-06 17:23:59
Documents
2
Period of Report
2022-09-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_166249940545901.html 3  
1 FORM 3 wf-form3_166249940545901.xml 3 1754
2 TM EXHIBIT LIST - EXHIBIT 24 - POWER OF ATTORNEY TXT exhibit24-poaxtimothymoore.htm EX-24 3772
  Complete submission text file 0001789769-22-000079.txt   6896
Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVE. SANTA MONICA CA 90404
Business Address
MOORE TIMOTHY L. (Reporting) CIK: 0001669207 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40215 | Film No.: 221229138

Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Issuer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)